Since more than 40 years liposomes have being extensively studied for their potential as
carriers of anticancer drugs. The basic principle behind their use for cancer treatment …

Surface functionalization of liposomes can play a key role in overcoming the current
limitations of nanocarriers to treat solid tumors, ie, biological barriers and physiological …

Nanotechnology has recently gained lots of interest in drug delivery due to its potential to
improve the therapeutic outcomes of various diseases. Particularly, a wide range of different …

Liposomes are highly advantageous platforms for drug delivery. To improve the colloidal
stability and avoid rapid uptake by the mononuclear phagocytic system of conventional …

In nanoparticle (NP)-mediated drug delivery, liposomes are the most widely used drug
carrier, and the only NP system currently approved by the FDA for clinical use, owing to their …

While small hydrophilic therapeutic molecules have proved to be exceptionally effective in
curing diseases, their in vivo efficacy remains low. Small molecule therapeutics infused in …

Since the discovery of liposomes by Alec Bangham in mid-1960s, these phospholipid
vesicles have been widely used as pharmaceutical carriers. Liposomes have been …

Liposomes have been exploited for pharmaceutical purposes, including diagnostic imaging
and drug and gene delivery. The versatility of liposomes as drug carriers has been …

Nanoliposome, or submicron bilayer lipid vesicle, is a new technology for the encapsulation
and delivery of bioactive agents. The list of bioactive material that can be incorporated to …

Liposomes are microscale lipid bilayer vesicles, widely employed for solubilizing drugs and
delivering them to the body with precise targeting and controlled release. The nanoscale …